about
Aqueous Humor Levels of Different Interleukins 1-β, 2, 6 and 10, Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in Uveitis Treated with Adalimumab.Adalimumab for Ocular Inflammation.Pharmacotherapy of scleritis: current paradigms and future directions.TNF inhibition for ophthalmic indications: current status and outlook.Does cyclophosphamide still have a role in the treatment of severe inflammatory eye disease?Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.New pharmacotherapy options for noninfectious posterior uveitis.The Use of Biologic Therapies in Uveitis.IL-6 blockade in the management of non-infectious uveitis.Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients.Retinal function and morphology in the rabbit eye after intravitreal injection of the TNF alpha inhibitor adalimumab.The promise and limitations of TNF-α inhibition for uveitis.Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review.Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis.Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation.
P2860
Q35584483-6DA69FFA-A9E0-464A-93BF-5B8E9F322440Q37276953-A7C4651D-D9BB-4142-B0C6-D8482FBA665FQ37466204-275A34EA-5B9F-44BF-9B00-73DD2A73964BQ38097327-ED022FBC-1B05-449C-B0CA-B53F89815970Q38170477-393BDB3D-599F-4EC0-8F06-3986F6B7418FQ38172584-44D5FBB9-55B1-4CF7-9E8B-A94A2399CFA8Q38253095-39E1B590-0903-44B1-8A89-C2A3458F1288Q38272248-30B87C34-667F-4D1C-BF52-574575CDA731Q40204739-04BED3DB-93BF-45AD-B7AA-92D5DBE0CF7EQ40488997-35E4BF63-37C7-4E8F-B33F-49073C015FF4Q43016617-F6B248F4-79DB-4115-8FD8-091E967DDBF7Q46124138-12A83415-C989-425D-8141-931F1ADCC405Q47378653-1FCDC8B3-2283-4DD3-94E9-2969F66C1C59Q49494558-5BA87E6A-9AB4-4AD6-8A22-23DE90017484Q50075113-4230ADED-51F5-49A4-B92C-53B84069379DQ50091416-3AF9FCC0-A66E-4CDF-8A9B-574DAE8D6E07
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Infliximab and adalimumab for uveitis.
@en
Infliximab and adalimumab for uveitis.
@nl
type
label
Infliximab and adalimumab for uveitis.
@en
Infliximab and adalimumab for uveitis.
@nl
prefLabel
Infliximab and adalimumab for uveitis.
@en
Infliximab and adalimumab for uveitis.
@nl
P2093
P2860
P1476
Infliximab and adalimumab for uveitis.
@en
P2093
Agnieszka Nagpal
Elizabeth Esterberg
Joseph N Martel
Nisha R Acharya
P2860
P356
10.3109/09273948.2011.633205
P577
2012-02-01T00:00:00Z